Epidemiology and molecular pathology of gallbladder cancer

Ca-A Cancer Journal for Clinicians

Volumn 51, Issue 6, 2001, Pages 349-364

  Lazcano Ponce, Eduardo C ^a   Miquel, J F ^b   Muñoz, Nubia ^c   Herrero, Rolando ^c   Ferrecio, Catterina ^d   Wistuba, Ignacio I ^b   De Ruiz, Patricia Alonso ^b   Urista, Gerardo Aristi ^e   Nervi, Flavio ^b  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d Hospital Mexico Costa Rica   (Costa Rica)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN INDIAN; BRAZIL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CHOLECYSTECTOMY; CHOLELITHIASIS; COLOMBIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CZECH REPUBLIC; ECUADOR; ENVIRONMENTAL EXPOSURE; FEMALE; GALLBLADDER CANCER; GALLSTONE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; MALE; NORTH AMERICA; OBESITY; PATHOLOGY; PERU; POLAND; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SLOVAKIA; SOUTH AMERICA;

EID: 0035572863     PISSN: 00079235     EISSN: None     Source Type: Journal    
DOI: 10.3322/canjclin.51.6.349     Document Type: Review

References (130)

1. Carcinoma of the gallbladder
2. Natural history study of gallbladder cancer
3. Epidemiological aspects of gallbladder and biliary tract neoplasm
4. Liver, gallbladder, extrahepatic bile ducts, and pancreas
5. Carcinoma of the gallbladder: Histologic types, stage of disease, grade, and survival rates
6. Poor prognosis of gallbladder cancer persists regardless of improved diagnostic methods
7. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing
8. Frequency of gallbladder cancer in Chile, a high risk area
9. Epidemiología Descriptiva del Cáncer Digestivo en Chile (1982-1991): Una Aproximación desde la Mortalidad
10. Risk factors for gallbladder cancer. An international collaborative case control study
11. Carcinoma of the gallbladder in a population of southwestern American Indians
12. Epidemiology of gallbladder cancer: A synthesis of recent data
13. Descriptive epidemiology of gallbladder cancer in Europe
14. Epidemiology of digestive tract cancers in India IV. Gall bladder and pancreas
15. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris
16. Individual admixture estimates: Disease associations and individual risk of diabetes and gallbladder disease among Mexican-Americans in Starr County, Texas
17. Increasing gall-bladder cancer mortality rate during the last decade in Chile, a high-risk area
18. The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. A commentary on the second edition
19. The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ
20. Carcinoma in situ of the gallbladder. A clinicopathologic study of 18 cases
21. Gallbladder cancer in a high risk area: Morphological features and spread patterns
22. Gallbladder carcinoma
23. Preneoplastic lesions and gallbladder cancer: An estimate of the period required for progression
24. Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates
25. Gallbladder adenocarcinoma: The prognostic significance of histologic grade
26. Radical surgery for gallbladder cancer: Current options
27. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage
28. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas
29. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union
30. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile
31. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder
32. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis
33. Detection of ras oncogene point mutations and simultaneous proliferative fraction estimation in gallbladder cancer
34. K-ras gene mutation in gall bladder carcinomas and dysplasia
35. K-ras and p53 mutations in Stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct
36. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction
37. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation
38. Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts
39. Genetic abnormalities involved in the pathogenesis of gallbladder carcinoma
40. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder
41. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas
42. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions
43. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater
44. p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder
45. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: Correlation with tumor grade and survival
46. High frequency of p53 gene mutation in adenocarcinomas of the gallbladder
47. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: An immunohistochemical study
48. Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene
49. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts
50. p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions
51. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis
52. TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns
53. p53 tumour suppressor gene protein expression in early and advanced gallbladder carcinoma
54. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma
55. Correlation of p53 protein expression with gene mutation in gall-bladder carcinomas
56. Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile
57. Mutation of the p53 gene in gallbladder cancer
58. From gene to carcinogen: A rapidly evolving field in molecular epidemiology
59. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes
60. Biliary neoplasia in Gardner's syndrome
61. Carcinoma and polyps of the gallbladder associated with Peutz-Jeguers syndrome
62. Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union
63. Anomalous pancreaticobiliary ductal union-an etiologic association of gallbladder cancer and adenomyomatosis
64. The prevention of carcinoma of the gallbladder
65. Cholelithiasis in the aetiology of gallbladder neoplasms
66. Risk factors for biliary tract cancers
67. Ultrasonographic evidence of association of polyps and stones with gallbladder cancer
68. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas
69. Epidemiologic Aspects of Gallbladder Cancer: A case control study of the SEARCH Program of the International Agency for Research on Cancer
70. A population based case control study of cancer of the bile ducts and gallbladder in Quebec, Canada
71. Risk factors for gallbladder cancer: A Polish case control study
72. Carcinoma of the gallbladder and extrahepatic bile duct in autopsy cases of the aged, with special reference to its relationship to gallstones
73. Combined oral contraceptives and gallbladder cancer. The WHO collaborative study of neoplasia and steroid contraceptives
74. Gallstones, gallbladder cancer, and other gastrointestinal malignancies. An Epidemiologic study in Rochester, Minnesota
75. Incidence of Salmonella typhi infection in symptomatic cholelithiasis in an endemic area. A prospective study
76. Gallstone size and the risk of gallbladder cancer
77. Carcinoma of the gallbladder. A possible regional predisposition in the western Cape and northern Cape
78. Gallstone size and the risk of gallbladder cancer
79. Does bile promote extracolonic cancer?
80. Geographic differences in the operative incidence and type of pigment gallstones and in the noncholesterol components of cholesterol gallstones
81. The natural course of gallbladder disease: Eleven year review of 781 non-operated cases
82. Epidemiology of gallbladder cancer: A synthesis of recent data
83. Some diseases characteristic of modern western civilization
84. Pathogenesis of cholesterol gallstones: A parsimonious hyphotesis
85. Factors associated with gallstone disease in the MICOL experience
86. High prevalence of cholelithiasis in a low income Mexican population: An ultrasonographic survey
87. Prevalence and associated factors for gallstone disease: Results of a population survey in Spain
88. Risk of asymptomatic and symptomatic gallstones in moderately obese women: A longitudinal follow-up study
89. The relation of physical activity to risk for symptomatic gallstone disease in men
90. Age is one of the risk factors in developing gallstone disease in Taiwan
91. Gallstone prevalence in Germany. The Ulm gallbladder stone study
92. Risk factors for gallstone disease in Mexicans are similar to those found in Mexican-Americans
93. Gallstone disease in high altitude Peruvian rural populations
94. Diet, physical activity, and gallstones: A population based, case control study in southern Italy
95. A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men
96. Gallstone disease risk in relation to body mass index and waist to hip ratio in Japanese men
97. Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men
98. Weight, diet and risk of symtomatic gallstones and middle age women
99. Diet, alcohol, and relative weight in gallstone disease: A case control study
100. Gallbladder function in the human female: Effect of the ovulatory cycle, pregnancy, and contraceptive steroids
101. Oral contraceptives, pregnancy, and endogenous oestrogen in gallstone disease: A case control study
102. Parity and cancers of the gall bladder and the extrahepatic bile ducts
103. Weight, diet, and the risk of symptomatic gallstones in middle-aged women
104. Contributions of obesity and weight loss to gallstone disease
105. Association of a history of gallbladder disease with reduced concentration of high-density-lipoprotein cholesterol
106. Family history and the risk of liver, gallbladder, and pancreatic cancer
107. Genetic factors in gallstone disease
108. Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease
109. A case control study of biliary tract cancer in Niigata Prefecture, Japan
110. Vaccination against infectious agents associated with human cancer
111. Cancer mortality in chronic typhoid and paratyphoid carriers
112. The association between typhoid carriage, typhoid infection and subsequent cancer at a number of sites
113. Salmonella carrier state, chronic bacterial infection and gallbladder carcinogenesis
114. Glucuronidase activity in Salmonella typhi and parathyphi
115. Chronic typhoid carriage and carcinoma of the gallbladder
116. Les toxiques industriels sont-ils un facteur de risque du cancer de la vesicule biliaire?
117. Retrospective Cohort Study of Workers of a Synthetic Textiles Plant in Quebec: I. General Mortality
118. Randon exposure and cancers other than lung cancer among uranium miners in West Bohemia
119. Elective Cholecystectomy and carcinoma of the gallbladder
120. Billiary tract cancer in Chile
121. Cholecystectomy and changing mortality from gallbladder cancer
122. Hospital discharges and length of stay: Short stay hospitals, United States, 1972
123. Decreasing frequency of cholecystectomies in the countries of Stockholm and Uppsala, Sweden
124. Prophylactic cholecystectomy of expectant management for silent gallstones. A decision analysis
125. The risk ratio is insufficient for clinical decision. The case of prophylactic cholecystectomy
126. Treatment of gallstones